Filing Details
- Accession Number:
- 0000950103-21-002447
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-17 20:04:00
- Reporting Period:
- 2021-02-12
- Accepted Time:
- 2021-02-17 20:04:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1828182 | Signify Health Inc. | SGFY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1357695 | H Brandon Hull | C/O Signify Health, Inc. 800 Connecticut Avenue Norwalk CT 06854 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class B Common Stock | Acquisiton | 2021-02-12 | 1,030,500 | $0.01 | 1,030,500 | No | 4 | A | Direct | |
Class A Common Stock | Acquisiton | 2021-02-16 | 7,916 | $0.00 | 7,916 | No | 4 | A | Direct | |
Class A Common Stock | Acquisiton | 2021-02-16 | 13,900 | $24.00 | 21,816 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | LLC Units in Cure Aggregator, LLC | Acquisiton | 2021-02-12 | 1,030,500 | $0.00 | 1,030,500 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,030,500 | No | 4 | A | Direct |
Footnotes
- These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC.
- Represents a grant of restricted stock units on February 16, 2021 that will vest on the first anniversary of the grant date.
- These securities were purchased through the Issuer's directed share program in connection with its initial public offering.
- The LLC Units service-vest 25% on each of February 1, 2019, 2020, 2021 and 2022 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire.